Condition: Homocystinuria Due to CBS Deficiency · Sponsor: Travere Therapeutics, Inc.
The purpose of the study is to characterize the clinical course of homocystinuria in pediatric and adult patients aged 1 to 65 years under current clinical management practices
This description comes directly from the study's public registry record.
Travere Call Center · 1-877-659-5518 · medinfo@travere.com
Always discuss trial participation with your own doctor first.
| Travere Investigational Site - Virtual Site | Culver City, California, United States | Completed |
| Travere Investigational Site (Enrolling 1 to <5 Year-olds Only) | Aurora, Colorado, United States | Recruiting |
| Travere Investigational Site (Enrolling 1 to <5 Year-olds Only) | Washington D.C., District of Columbia, United States | Recruiting |
| Travere Investigational Site | Atlanta, Georgia, United States | Completed |
| Travere Investigational Site | Indianapolis, Indiana, United States | Completed |
| Travere Investigational Site | Boston, Massachusetts, United States | Completed |
| Travere Investigational Site (Enrolling 1 to <5 Year-olds Only) | Philadelphia, Pennsylvania, United States | Recruiting |
| Travere Investigational Site | Dublin, Ireland | Recruiting |
| Travere Investigational Site | Doha, Qatar, Qatar | Recruiting |
| Travere Investigational Site | Doha, Qatar | Recruiting |
| Travere Investigational Site | Salford, Manchester, United Kingdom | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02998710